Hereditary sensory and autonomic neuropathy with deafness and global delay
heh-reh-di-tair-ee sen-suh-ree and aw-toh-nom-ik noo-rop-uh-thee
Also known as: HSAN with deafness and global delay, TECPR2-related neuropathy
At a Glance
What is Hereditary sensory and autonomic neuropathy with deafness and global delay?
Hereditary sensory and autonomic neuropathy with deafness and global delay is a rare genetic disorder. It affects the nervous system, particularly the sensory and autonomic nerves, leading to a loss of sensation and autonomic dysfunction. The condition is caused by mutations in specific genes, such as TECPR2, which disrupt normal nerve function. Over time, individuals may experience progressive loss of sensation, difficulty with balance, and hearing loss. Early symptoms often include delayed developmental milestones and insensitivity to pain. As the condition progresses, affected individuals may develop more severe neurological impairments and hearing loss. Early diagnosis is crucial to manage symptoms and improve quality of life. Families may face significant challenges due to the need for ongoing medical care and support. The prognosis varies, but many individuals require lifelong assistance with daily activities. Daily life for affected individuals often involves managing sensory deficits, hearing impairments, and developmental delays. Supportive therapies and interventions can help improve function and quality of life.
Medical Definition
Hereditary sensory and autonomic neuropathy with deafness and global delay is a genetic disorder characterized by pathological degeneration of sensory and autonomic neurons. Histological findings typically reveal loss of myelinated and unmyelinated fibers in peripheral nerves. It is classified under hereditary sensory and autonomic neuropathies, specifically associated with TECPR2 mutations. Epidemiologically, it is an extremely rare condition with a prevalence of approximately 1 in 1,000,000. The disease course involves progressive sensory loss, autonomic dysfunction, and developmental delays. Early intervention and supportive care are essential to manage symptoms and improve outcomes.
Hereditary sensory and autonomic neuropathy with deafness and global delay Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Clinically, this manifests as an inability to feel pain, leading to unnoticed injuries. The biological mechanism involves dysfunction in the sensory nerves responsible for transmitting pain signals to the brain. Over time, this can result in repeated injuries and complications such as infections or joint damage. In daily life, patients must be vigilant about checking for injuries, and protective measures like wearing appropriate footwear can help.
Hearing loss in this condition is often sensorineural, affecting the inner ear or auditory nerve. It results from genetic mutations that impact the development or function of auditory pathways. Progression can vary, with some experiencing gradual worsening over time. Hearing aids or cochlear implants can significantly improve communication and quality of life.
This symptom presents as a delay in reaching developmental milestones such as walking or talking. It is caused by neurological impairments affecting cognitive and motor functions. The delay can persist into adulthood, impacting educational and occupational opportunities. Early intervention with therapies can enhance skill development and adaptive functioning.
Common
Autonomic dysfunction can manifest as issues with temperature regulation, blood pressure, or sweating. It is due to impaired autonomic nerve function, which controls involuntary bodily processes. Symptoms may fluctuate, leading to episodes of dizziness or abnormal sweating. Management includes lifestyle adjustments and medications to stabilize autonomic functions.
Muscle weakness is characterized by reduced strength and endurance, often affecting mobility. It arises from nerve damage that disrupts signals between the brain and muscles. Over time, weakness can lead to muscle atrophy and decreased physical activity. Physical therapy and exercise can help maintain muscle function and improve mobility.
Patients may experience frequent infections, particularly in areas with sensory loss. This occurs because injuries go unnoticed and untreated, leading to infection. The risk of infection can increase over time if injuries are not properly managed. Regular medical check-ups and prompt treatment of wounds are essential to prevent complications.
Less Common
Gastrointestinal issues can include constipation or diarrhea, reflecting autonomic nervous system involvement. These symptoms result from impaired nerve control over digestive processes. They may be intermittent or persistent, affecting nutritional status and comfort. Dietary modifications and medications can help manage these symptoms effectively.
Orthopedic complications such as joint deformities or fractures can occur due to repeated injuries and lack of pain sensation. The underlying cause is the cumulative effect of unrecognized trauma and abnormal stress on bones and joints. Over time, these complications can lead to significant mobility issues. Surgical interventions and orthopedic supports may be necessary to maintain function and prevent further damage.
What Causes Hereditary sensory and autonomic neuropathy with deafness and global delay?
Hereditary sensory and autonomic neuropathy with deafness and global delay is primarily caused by mutations in the TECPR2 gene, located on chromosome 14q32. The TECPR2 gene encodes a protein involved in autophagy, a cellular process that degrades and recycles damaged organelles and proteins. Mutations in TECPR2 lead to a truncated or misfolded protein, impairing its ability to facilitate autophagosome formation. This disruption in autophagy results in the accumulation of damaged mitochondria and other organelles, leading to cellular stress and dysfunction. The impaired autophagic process particularly affects neurons, which are highly dependent on efficient protein turnover and organelle quality control. Consequently, there is a progressive degeneration of sensory and autonomic neurons, contributing to the neuropathic symptoms observed. Neuroinflammation may exacerbate neuronal damage, as the accumulation of cellular debris can activate microglia and other immune responses. White matter degeneration occurs due to the loss of myelinated nerve fibers, which disrupts signal transmission. The specific pattern of symptoms, including sensory loss, autonomic dysfunction, and deafness, arises from the selective vulnerability of certain neuronal populations. Variability in disease severity among patients can be attributed to the type of mutation, genetic background, and environmental factors. Some mutations may partially retain protein function, leading to milder phenotypes. Additionally, compensatory mechanisms in different individuals may influence the extent of neuronal damage and symptom manifestation. The global developmental delay is likely due to the widespread impact of autophagy dysfunction on neuronal development and maintenance. Understanding these molecular and cellular mechanisms is crucial for developing targeted therapies.
How is Hereditary sensory and autonomic neuropathy with deafness and global delay Diagnosed?
Typical age of diagnosis: Diagnosis typically occurs in early childhood when symptoms such as sensory loss, autonomic dysfunction, and developmental delays become apparent. Parents often notice delayed milestones and lack of response to pain. Early recognition is crucial for management and genetic counseling. Diagnosis may be delayed if symptoms are mild or attributed to other conditions.
The clinician looks for signs of sensory loss, autonomic dysfunction, and developmental delays. A detailed family history is important to identify any hereditary patterns. Physical examination may reveal reduced pain and temperature sensation, as well as signs of autonomic instability. This step helps to differentiate from other neuropathies and directs towards further testing.
MRI is often used to assess the central nervous system and peripheral nerves. Specific abnormalities may include nerve atrophy or other structural changes. Imaging findings support the diagnosis by excluding other causes of neuropathy such as tumors or demyelinating diseases. Differential diagnoses like multiple sclerosis or spinal cord lesions are also considered.
Blood tests may include metabolic panels and nerve conduction studies. Biomarkers such as elevated lactate or abnormal nerve conduction velocities are sought. Abnormal results may show reduced nerve conduction velocity, indicating neuropathy. These results guide the clinician towards genetic testing and further neurological evaluation.
Genes such as TECPR2 are sequenced to identify mutations. Mutations may include missense, nonsense, or deletions. Positive results confirm the diagnosis and provide a basis for genetic counseling. Family members can be tested to understand inheritance patterns and recurrence risks.
Hereditary sensory and autonomic neuropathy with deafness and global delay Treatment Options
Anticonvulsants such as gabapentin or pregabalin are used to manage neuropathic pain. These drugs work by modulating calcium channels to reduce neuronal excitability. Clinical evidence shows moderate efficacy in pain reduction, but they do not address the underlying neuropathy. Side effects may include dizziness, fatigue, and cognitive impairment. Long-term use requires monitoring for tolerance and effectiveness.
Techniques include tactile stimulation and proprioceptive training. The goal is to enhance sensory perception and improve motor function. Sessions are typically conducted 2-3 times per week for several months. Outcomes are measured by improved sensory thresholds and functional abilities. Long-term benefits include better quality of life and reduced injury risk.
Surgery is indicated for severe cases with compressive neuropathy. The procedure involves relieving pressure on affected nerves to restore function. Expected benefits include pain relief and improved nerve function. Risks include infection, nerve damage, and anesthesia complications. Post-operative care involves physical therapy and regular follow-up.
The team includes neurologists, geneticists, physical therapists, and psychologists. Interventions focus on pain management, mobility support, and developmental therapies. Psychosocial support includes counseling and support groups for families. Education covers disease management and genetic implications. Long-term monitoring involves regular assessments and adjustments to the care plan.
When to See a Doctor for Hereditary sensory and autonomic neuropathy with deafness and global delay
- Sudden loss of consciousness — this could indicate a severe autonomic dysfunction requiring immediate medical attention.
- Severe dehydration — due to autonomic dysfunction, this can lead to life-threatening complications if not treated promptly.
- Acute respiratory distress — may signify a critical autonomic failure affecting breathing, necessitating emergency intervention.
- Persistent high fever — could indicate an underlying infection or autonomic instability; seek medical advice.
- Unexplained weight loss — may suggest nutritional deficiencies or metabolic issues related to the condition.
- Progressive hearing loss — requires evaluation to adjust management and prevent further complications.
- Mild numbness in extremities — monitor for any progression or additional symptoms.
- Occasional dizziness — track frequency and triggers to discuss with a healthcare provider.
Hereditary sensory and autonomic neuropathy with deafness and global delay — Frequently Asked Questions
Is this condition hereditary?
This condition is typically inherited in an autosomal recessive pattern. This means both parents must carry a copy of the mutated gene to pass it to their child. De novo mutations, which are new mutations not inherited from parents, are rare. Carriers usually do not show symptoms but can pass the gene to offspring. Genetic counseling is recommended for affected families to understand risks and implications.
What is the life expectancy for someone with this condition?
Life expectancy can vary significantly depending on the severity and management of symptoms. Early onset often correlates with a more severe course and potentially reduced lifespan. Complications such as infections or respiratory issues are common causes of mortality. Effective management and treatment can improve quality of life and survival. Families should have realistic expectations and work closely with healthcare providers to optimize care.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves a combination of clinical evaluation, genetic testing, and sometimes nerve conduction studies. The time from first symptoms to diagnosis can vary, often taking months to years due to the rarity of the condition. Neurologists and geneticists are typically involved in the diagnostic process. Delays often occur due to symptom overlap with other conditions. Genetic testing ultimately confirms the diagnosis.
Are there any new treatments or clinical trials available?
Current research is exploring gene therapy and other novel treatments aimed at addressing the genetic root of the condition. ClinicalTrials.gov is a resource for finding ongoing trials and new treatment options. Patients should discuss potential participation in trials with their healthcare provider. While promising, these treatments may take years to become widely available. Staying informed about research developments is crucial.
How does this condition affect daily life and activities?
The condition can significantly impact mobility and self-care abilities, often requiring assistive devices. Educational challenges are common due to cognitive delays, necessitating special education services. Social and emotional difficulties may arise from communication barriers and physical limitations. The family burden can be substantial, with caregivers needing support and resources. Adaptations and community support can greatly enhance quality of life.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.TECPR2-Related Hereditary Sensory and Autonomic Neuropathy with Intellectual Disability.
Adam MP, Bick S, Mirzaa GM et al. · Unknown Journal · 1993 · PMID: 36137062
- 2.Hereditary Sensory and Autonomic Neuropathy Type II.
Adam MP, Bick S, Mirzaa GM et al. · Unknown Journal · 1993 · PMID: 21089229
- 3.Hereditary Sensory and Autonomic Neuropathies: Adding More to the Classification.
Schwartzlow C, Kazamel M · Curr Neurol Neurosci Rep · 2019 · PMID: 31222456
- 4.Genetic landscape of congenital insensitivity to pain and hereditary sensory and autonomic neuropathies.
Lischka A, Eggermann K, Record CJ et al. · Brain · 2023 · PMID: 37769650
- 5.Hereditary Sensory and Autonomic Neuropathy: A Case Series of Six Children.
Suthar R, Sharawat IK, Eggermann K et al. · Neurol India · 2022 · PMID: 35263888
- 6.Hereditary sensory and autonomic neuropathies.
Auer-Grumbach M · Handb Clin Neurol · 2013 · PMID: 23931820
- 7.Hereditary sensory and autonomic neuropathy types IV and V in Japan.
Haga N, Kubota M, Miwa Z et al. · Pediatr Int · 2015 · PMID: 25422087
- 8.Hereditary sensory and autonomic neuropathies: types II, III, and IV.
Axelrod FB, Gold-von Simson G · Orphanet J Rare Dis · 2007 · PMID: 17915006
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-07